MAY 12, 2019 3:11 PM PDT

Potential of Statins to Treat Multiple Sclerosis

WRITTEN BY: Nouran Amin

health.harvard.edu

A widely used therapeutic statin, simvastatin, which is intended to treat cholesterol was found to be medically beneficial for patients with secondary progressive Multiple Sclerosis (SPMS).

"Although this study cannot provide a final answer as to what exactly is the reason for the success of statins in progressive MS, it directs future researchers toward certain pathways," said lead author, Dr Arman Eshaghi (UCL Queen Square Institute of Neurology). "This paves the way to find better drug targets for an incurable disease such as MS."

Generally, multiple sclerosis (MS) affects how people walk, move, see, think, and feel and there is currently no cure for MS with little effective treatment for the secondary form.

Learn more about Multiple Sclerosis (MS):

The study, published in Proceedings of the National Academy of Sciences (PNAS), simvastatin was reanalyzed from earlier studies of Multiple Sclerosis-Statins trial data. The analysis resulted in a hypothesis that causal associations between simvastatin and the brain changes it leads to are a result of either directly or indirectly changing the patient's peripheral cholesterol level.

"Simvastatin is one of the most promising treatment prospects for secondary progressive MS in our lifetime. People with this form of the condition have been waiting decades for a drug that works, which is why there's such excitement around being able to start the trial," said Professor Chataway, who is leading the trial and is a co-author on the PNAS paper.

To examine if a reduction in cholesterol levels resulted in a positive impact on brain atrophy and on disability, two computational models were developed—a cholesterol-mediated model and a cholesterol-independent model. In the cholesterol-mediated model, the effects of simvastatin on clinical measures and brain atrophy were brought by changes in cholesterol. The cholesterol-independent model, simvastatin was shown to have a direct effect on the clinical and MRI outcome measures that are independent of the effects on serum cholesterol levels.

"Statins are naturally occurring, produced by some fungi, meaning that unlike most drugs that are designed for specific targets, they have (still after two decades of use in heart diseases) several unknown effects, and that is why this study is so important,” says Dr Eshaghi. "My study tells us that statins help patients with MS for reasons different from how they help people lower their cholesterol. For example, statins can modulate other elements that are produced in the pathways before cholesterol, but have indirect effects on the immune system."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 15, 2020
Cancer
JAN 15, 2020
Hope for patients with AML
Research published recently in the medical journal EMBO Molecular Medicine brings hope for leukemia patients with a report that a common and cheap drug may...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Frequent Cannabis Use Could Affect Driving Safety
A new study suggests that heavy marijuana users have the potential to be dangerous drivers. However, hazardous driving appears to be isolated to users who ...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Molecule Found in Oranges Could Treat Obesity
Scientists at Western University isolated a molecule from oranges and sweet tangerines called ‘nobiletin’. Through the studies on mice the mole...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
4 Potential Treatments for SARS-CoV-2 Currently Under Testing
Currently, no medicine nor vaccine has been approved as effective for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despi...
MAR 13, 2020
Drug Discovery & Development
MAR 13, 2020
Ibuprofen's Effects on Liver
Ibuprofen is a popular painkiller and over-the-counter (OTC) that belongs to a group of drugs referred to as nonsteroidal anti-inflammatory drugs, or NSAID...
Loading Comments...